Email This Release
Nestlé Skin Health的醫療解決方案公司Galderma發表nemolizumab治療中重度異位性皮膚炎2b期研究陽性結果
*
marks required fields
Recipient Name:
*
Recipient Email:
Message:
*
Enter security words: